We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Gilead Sciences Acquires EpiTherapeutics

News   May 07, 2015

 
Gilead Sciences Acquires EpiTherapeutics
 
 
 

RELATED ARTICLES

Epigenetic Map Paves the Way for Therapeutics to Combat Hearing Loss

News

A team has now created the first map of "methylation" — one of the body's main epigenetic signals — that reflects the functioning of the inner ear in its entirety.

READ MORE

Fluidic Analytics Raises $31m to Launch Two New Products in Lab Tools Pipeline and Unlock Biology Behind Major Diseases

News

Proteins and their behaviour are crucial to understanding how diseases develop, identifying the way that drugs interact with their targets, and developing new methods for matching the right treatment to the right patient at the right time.

READ MORE

On-demand Biologics

News

Many life-saving medicines, including insulin, antibodies and vaccines, are derived from living cells. These “biologics” can be difficult to obtain and store on the battlefield or in remote areas. That’s why scientists are trying to develop portable systems that can quickly manufacture small batches of protein therapeutics on demand.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE